Clinical trial
Early Non-invasive Detection of Progression of Mass Effect From Unilateral Brain Lesions
NCT04745884 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Non-invasive Detection of Progression of Mass Effect From Unilateral Brain Lesions
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 4, 2021
- Completion date
- December 2, 2024
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-traumatic hemispheric brain lesions